Prognostic value of morphological characteristics assessed by CT scan in patients with non‐small cell lung cancer treated with nivolumab

BACKGROUND: Nivolumab is known to demonstrate superior overall survival compared with docetaxel in pretreated non‐small cell lung cancer (NSCLC) patients. Programmed death‐ligand 1 (PD‐L1) expression is reported to predict the outcome of treatment by nivolumab in lung cancer patients. However, the s...

Descripción completa

Detalles Bibliográficos
Autores principales: Minemura, Hiroyuki, Moriya, Hiroshi, Imai, Hisao, Sugiyama, Tomohide, Yamada, Yutaka, Higuchi, Mitsunori, Kaira, Kyoichi, Ozaki, Yuki, Kanazawa, Kenya, Yokouchi, Hiroshi, Kasai, Takashi, Kaburagi, Takayuki, Suzuki, Hiroyuki, Minato, Koichi, Shibata, Yoko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705921/
https://www.ncbi.nlm.nih.gov/pubmed/33044045
http://dx.doi.org/10.1111/1759-7714.13695

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705921/
https://www.ncbi.nlm.nih.gov/pubmed/33044045
http://dx.doi.org/10.1111/1759-7714.13695

Ejemplares similares